With respect to the proinflammatory potential of P2X7 receptor by the release of inflammatory cytokines from peripheral macrophages, the therapeutic potential of P2X7 receptor blockade has been investigated in clinical trials addressing rheumatoid arthritis [123,124] and Crohn’s disease [125]. This evidence concerns the gene P2RX7 and rheumatoid arthritis.